| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
134,770,000 |
| Market
Cap: |
18.46(B) |
| Last
Volume: |
637,785 |
Avg
Vol: |
1,177,170 |
| 52
Week Range: |
$120.62 - $144.92 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Laboratories & Research |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 500 |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 724 |
| Guru Rank Value : 1.3 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Quest Diagnostics provides diagnostic information services. Co. is made up of two businesses: Diagnostic Information Services, which develops and delivers diagnostic information services, providing insights that allow and enable a range of customers, including patients, clinicians, hospitals, independent delivery networks (including hospital health systems), health plans, employers, accountable care organizations and direct contract entities; and Diagnostic Solutions, which includes Co.'s risk assessment services business, which provides solutions for insurers, and Co.'s healthcare information technology businesses, which provides solutions for healthcare providers.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
18,097 |
18,097 |
18,097 |
536,229 |
| Total Sell Value |
$2,309,019 |
$2,309,019 |
$2,309,019 |
$75,325,755 |
| Total People Sold |
4 |
4 |
4 |
7 |
| Total Sell Transactions |
7 |
7 |
7 |
25 |
| End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Ring Timothy M |
Director |
– • – |
2022-12-01 |
4 |
OE |
$53.13 |
$116,214 |
D/D |
2,025 |
26,174 |
|
- |
|
| Doherty Catherine T. |
SVP, Regional Businesses |
• – – |
2022-11-28 |
4 |
AS |
$148.92 |
$6,081,262 |
D/D |
(40,765) |
67,733 |
|
-4% |
|
| Doherty Catherine T. |
SVP, Regional Businesses |
• – – |
2022-11-28 |
4 |
OE |
$86.63 |
$3,531,472 |
D/D |
40,765 |
108,498 |
|
- |
|
| Kuppusamy Karthik |
SVP, Clinical SolutionsOfficer |
• – – |
2022-11-16 |
3/A |
IO |
$0.00 |
$0 |
I/I |
0 |
1,754 |
|
- |
|
| Gardner Mark A |
SVP of Molecular Gen & OncolOf |
• – – |
2022-11-16 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,002 |
|
-7% |
|
| Delaney Mark E |
SVP & Chief Commercial Officer |
• – – |
2022-11-16 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,731 |
|
-7% |
|
| Kuppusamy Karthik |
SVP, Clinical SolutionsOfficer |
• – – |
2022-11-16 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,396 |
|
-7% |
|
| Kuppusamy Karthik |
SVP, Clinical SolutionsOfficer |
• – – |
2022-11-16 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
7,960 |
|
-7% |
|
| Plewman Patrick |
SVP for Diagnostic ServicesOff |
• – – |
2022-11-16 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
8,924 |
|
-7% |
|
| Davis J. E. |
CEO and President |
• • – |
2022-11-01 |
4 |
A |
$0.00 |
$0 |
D/D |
13,980 |
80,788 |
|
- |
|
| Ring Timothy M |
Director |
– • – |
2022-11-01 |
4 |
S |
$144.06 |
$288,120 |
D/D |
(2,000) |
24,149 |
|
7% |
|
| Ring Timothy M |
Director |
– • – |
2022-11-01 |
4 |
OE |
$60.79 |
$122,136 |
D/D |
2,000 |
25,933 |
|
- |
|
| Deppe Michael J |
VP, Corp. Controller & CAO |
• – – |
2022-10-26 |
4 |
AS |
$145.00 |
$2,247,065 |
D/D |
(15,497) |
32,013 |
|
-6% |
|
| Deppe Michael J |
VP, Corp. Controller & CAO |
• – – |
2022-10-26 |
4 |
OE |
$52.17 |
$833,598 |
D/D |
15,497 |
47,503 |
|
- |
|
| Gregg Vicky B |
Director |
– • – |
2022-10-19 |
4 |
A |
$127.67 |
$9,447 |
D/D |
74 |
17,066 |
|
- |
|
| Ring Timothy M |
Director |
– • – |
2022-10-03 |
4 |
AS |
$123.39 |
$246,780 |
D/D |
(2,000) |
23,933 |
|
15% |
|
| Ring Timothy M |
Director |
– • – |
2022-10-03 |
4 |
OE |
$61.23 |
$122,450 |
D/D |
2,000 |
25,933 |
|
- |
|
| Ring Timothy M |
Director |
– • – |
2022-09-01 |
4 |
AS |
$125.02 |
$250,040 |
D/D |
(2,000) |
23,933 |
|
17% |
|
| Ring Timothy M |
Director |
– • – |
2022-09-01 |
4 |
OE |
$61.23 |
$122,450 |
D/D |
2,000 |
25,933 |
|
- |
|
| Ring Timothy M |
Director |
– • – |
2022-08-01 |
4 |
AS |
$136.04 |
$272,080 |
D/D |
(2,000) |
23,933 |
|
9% |
|
| Ring Timothy M |
Director |
– • – |
2022-08-01 |
4 |
OE |
$56.25 |
$121,709 |
D/D |
2,000 |
25,933 |
|
- |
|
| Samad Samer Abdul |
Executive Vice President & CFO |
• – – |
2022-07-25 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
15,674 |
|
14% |
|
| Gregg Vicky B |
Director |
– • – |
2022-07-20 |
4 |
A |
$134.47 |
$9,413 |
D/D |
70 |
16,992 |
|
- |
|
| Ring Timothy M |
Director |
– • – |
2022-07-01 |
4 |
AS |
$133.47 |
$266,940 |
D/D |
(2,000) |
23,933 |
|
12% |
|
| Ring Timothy M |
Director |
– • – |
2022-07-01 |
4 |
OE |
$56.25 |
$114,911 |
D/D |
2,000 |
25,933 |
|
- |
|
1532 Records found
|
|
Page 6 of 62 |
|
|
1.30 (0.96%) 
